Published in Volume
51, Issue 12
(December 1972)J Clin Invest.
1972, The American Society for
A New Radioimmunoassay for Plasma l-Triiodothyronine: Measurements in Thyroid Disease and in Patients Maintained on Hormonal Replacement
Endocrine Research Laboratory, Montefiore Hospital, Bronx, New York 10467Division of Endocrinology, Department of Medicine, Montefiore Hospital, Bronx, New York 10467Medical Center and the Albert Einstein College of Medicine, Bronx, New York 10467
Published December 1972
A new procedure for the radioimmunoassay of l-triiodothyronine (T3) in human plasma is described in which the iodothyronines are separated from the plasma proteins before incubation with a specific antiserum to T3. The antibody bound and free T3 are separated with dextran-coated charcoal. In this system, the mean recovery of T3 added to plasma was 97.9% and both in vitro conversion of l-thyroxine (T4) to T3 and cross-reaction between T4 and the anti-T3 antibody were undetectable (less than 0.1%). The assay procedure allowed the measurement of T3 in up to 0.5 ml of plasma resulting in improved assay sensitivity (6 ng/100 ml). The mean plasma T3 in normal subjects was 146±24 ng/100 ml (sd). Mean T3 concentration was increased in hyperthyroidism (665±289 ng/100 ml) and decreased in hypothyroidism (44±26 ng/100 ml). In patients with severe hypothyroidism, plasma T3 was between 7 and 30 ng/100 ml. Plasma T3 concentration was relatively constant throughout the day in three euthyroid subjects. In contrast, in hypothyroid subjects on replacement therapy with T3, a T4: T3 combination or desiccated thyroid plasma T3 was markedly elevated for several hours after ingestion of the medication. Plasma T3 was unchanged throughout the day in patients treated with T4. Thus, insofar as plasma T3 levels are concerned, replacement therapy with T4 appears to mimic the euthyroid state more closely than other preparations.
Click on an image below to see the page. View
PDF of the complete article